BioWorld

Oct. 1, 2002

View Archived Issues

BioMarin To Launch Phase III Trials With CABG Heparinase

Read More

Burning Red Pepper Sensation, Powered By Capsaicin, Hints At Pain-Suppressing Analgesics

Read More

NicOx Grants AstraZeneca Exclusive License For Japan

Read More

Angiotech To Acquire Cohesion Through $42M All-Stock Merger

Read More

Genelabs Synthesizes Family Of DNA-Binding Fungicidal Molecules

Read More

Other News To Note

Read More

IntraBiotics' Iseganan Fails To Reduce Mucositis In Phase III

IntraBiotics Pharmaceuticals Inc. stopped development of iseganan for mucositis following a Phase III failure. (BioWorld Today) Read More